Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
7.80
-0.13 (-1.64%)
Nov 13, 2026, 3:04 PM CST

SHE:000590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
98.43177.71177.29189.77235.42250.68
Trading Asset Securities
25---25.1175.15
Cash & Short-Term Investments
123.43177.71177.29189.77260.53325.83
Cash Growth
-34.60%0.24%-6.58%-27.16%-20.04%-4.99%
Accounts Receivable
81.7968.94103.15154.4117.16124.81
Other Receivables
19.2316.1490.2860.5130.116
Receivables
101.0285.08193.43214.91147.27130.82
Inventory
122.85109.57124.78130.09118.2286.59
Prepaid Expenses
-0.522.32-0.030
Other Current Assets
16.555.982.174.793.0610.65
Total Current Assets
363.86378.87499.99539.55529.11553.88
Property, Plant & Equipment
321.78308.31312.66293.81289.75240.89
Long-Term Investments
23.4523.0220.0320.91919
Goodwill
--13.2131.64137.14-
Other Intangible Assets
119.61123.45131.06132.33157.44133.69
Long-Term Accounts Receivable
-2.033.095.057.42-
Long-Term Deferred Tax Assets
14.7514.98.184.095.234.97
Long-Term Deferred Charges
5.927.46.293.322.931.82
Other Long-Term Assets
26.4431.4918.9220.421913.57
Total Assets
875.8889.471,0131,1511,167967.83

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
92.8864.0773.2483.5564.0141.67
Accrued Expenses
23.438.9743.8846.6250.840.37
Short-Term Debt
--0.75-25.82-
Current Portion of Long-Term Debt
10.420.0611.011010.1-
Current Portion of Leases
-1.12.942.362.693
Current Income Taxes Payable
2.980.036.82.33.43.85
Current Unearned Revenue
25.0336.1545.3350.1256.1353.42
Other Current Liabilities
37.1640.9552.3153.8258.4544.68
Total Current Liabilities
191.86201.33236.26248.77271.42186.98
Long-Term Debt
70.575082.228090-
Long-Term Leases
0.310.811.493.075.185.59
Long-Term Unearned Revenue
44.1744.9843.9942.4444.3746.29
Long-Term Deferred Tax Liabilities
5.135.815.155.917.470.02
Other Long-Term Liabilities
38.8837.0543.0742.7246.0946.62
Total Liabilities
350.91339.98412.18422.92464.53285.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
239.47239.47239.47239.47239.47239.47
Additional Paid-In Capital
473.95473.95474.06474.06474.06474.06
Retained Earnings
-189.62-165.81-115.2910.18-15.06-33.21
Total Common Equity
523.8547.61598.25723.72698.47680.32
Minority Interest
1.091.872.994.494.032
Shareholders' Equity
524.89549.49601.23728.2702.5682.32
Total Liabilities & Equity
875.8889.471,0131,1511,167967.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
81.2871.9798.4295.43133.798.58
Net Cash (Debt)
42.15105.7478.8794.34126.74317.24
Net Cash Growth
-47.63%34.07%-16.40%-25.56%-60.05%-6.13%
Net Cash Per Share
0.180.440.330.390.531.32
Filing Date Shares Outstanding
239.04239.47239.47239.47239.47239.47
Total Common Shares Outstanding
239.04239.47239.47239.47239.47239.47
Working Capital
172177.54263.73290.78257.69366.9
Book Value Per Share
2.192.292.503.022.922.84
Tangible Book Value
404.19424.17453.98459.75403.89546.63
Tangible Book Value Per Share
1.691.771.901.921.692.28
Buildings
-253.52267.95247.28243.93198.81
Machinery
-228.54220.21197.31189.09174.95
Construction In Progress
-23.098.8123.8315.214.18